Recently I was made aware that the drug Zelnorm (tegaserod maleate), a prescription medication approved for short-term treatment of women with irritable bowel syndrome (IBS) with constipation and for patients younger than 65 with chronic constipation, was recalled after new data showed that a statistically significant number of cardiovascular problems occurred in patients.

For more information, go to this site.


Comments


Name (required)

Email (required)

Website

Speak your mind